Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review

Table 2

Prevalence of myeloma defining events among multiple myeloma patients at KNH.

Myeloma defining events	Frequency	(%)
Anaemia	147/207	71
Mild (Hb 10 g/dl)	5 (3.4%)
Moderate (Hb 7–9 g/dl)	88 (59.9%)
Severe (Hb < 7 g/dl)	54 (36.7%)
Renal dysfunction (creatinine levels >177 μmol/l)	79/207	38.2
Hypercalcemia (calcium level >2.75 mmol/l)	127/178	55.5
One or more >5 mm osteolytic bone lesions	126/137	91.9